Outcomes of TIPS for Treatment of Gastroesophageal Variceal Hemorrhage (original) (raw)

Semin intervent Radiol 2014; 31(03): 252-257
DOI: 10.1055/s-0034-1382793

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Ahmad Parvinian

1Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois

Ron C. Gaba

1Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois

› Author Affiliations

Further Information

Publication History

Publication Date:
20 August 2014 (online)

Abstract

Variceal hemorrhage is a life-threatening complication of cirrhosis that requires a multidisciplinary approach to management. The transjugular intrahepatic portosystemic shunt (TIPS) procedure is a minimally invasive image-guided intervention used for secondary prevention of bleeding and as salvage therapy in acute hemorrhage. This review focuses on the role of TIPS in the setting of variceal hemorrhage, with emphasis on the pathophysiology and conventional management of variceal hemorrhage, current and emerging indications for TIPS creation, TIPS clinical outcomes, and the role of adjuvant embolotherapy.

Keywords

transjugular intrahepatic portosystemic shunt - gastroesophageal varices - hemorrhage - embolotherapy - interventional radiology

• References

• 1 Maruyama H, Yokosuka O. Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol 2012; 2012 (2012) 895787
• 2 Turon F, Casu S, Hernández-Gea V, Garcia-Pagán JC. Variceal and other portal hypertension related bleeding. Best Pract Res Clin Gastroenterol 2013; 27 (5) 649-664
• 3 Kim T, Shijo H, Kokawa H , et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25 (2) 307-312
• 4 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (6) 1343-1349
• 5 Merkel C, Zoli M, Siringo S , et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000; 95 (10) 2915-2920
• 6 Sanyal AJ, Freedman AM, Luketic VA , et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112 (3) 889-898
• 7 D'Amico G, De Franchis R ; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38 (3) 599-612
• 8 Albillos A. Preventing first variceal hemorrhage in cirrhosis. J Clin Gastroenterol 2007; 41 (Suppl. 03) S305-S311
• 9 Garcia N, Sanyal AJ. Medical management of complications secondary to portal hypertension. In: Patel NH, Haskal ZJ, Kerlan RK, , eds. Portal Hypertension: Diagnosis and Interventions. 2nd ed. Fairfax VA: The Society of Cardiovascular and Interventional Radiology; 2001: 47-62
• 10 de Franchis R ; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53 (4) 762-768
• 11 Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology 2008; 134 (6) 1715-1728
• 12 Merkel C, Marin R, Angeli P , et al; Gruppo Triveneto per l'Ipertensione Portale. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004; 127 (2) 476-484
• 13 Reiberger T, Ulbrich G, Ferlitsch A , et al; Vienna Hepatic Hemodynamic Lab. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2013; 62 (11) 1634-1641
• 14 García-Pagán JC, Reverter E, Abraldes JG, Bosch J. Acute variceal bleeding. Semin Respir Crit Care Med 2012; 33 (1) 46-54
• 15 Loffroy R, Estivalet L, Cherblanc V , et al. Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol 2013; 19 (37) 6131-6143
• 16 Gazzera C, Righi D, Doriguzzi Breatta A , et al. Emergency transjugular intrahepatic portosystemic shunt (TIPS): results, complications and predictors of mortality in the first month of follow-up. Radiol Med (Torino) 2012; 117 (1) 46-53
• 17 Orloff MJ, Vaida F, Haynes KS, Hye RJ, Isenberg JI, Jinich-Brook H. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg 2012; 16 (11) 2094-2111
• 18 Boyer TD, Haskal ZJ ; American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology 2010; 51 (1) 306
• 19 García-Pagán JC, Caca K, Bureau C , et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
• 20 Garcia-Pagán JC, Di Pascoli M, Caca K , et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013; 58 (1) 45-50
• 21 Kamath PS, Wiesner RH, Malinchoc M , et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33 (2) 464-470
• 22 Salerno F, Merli M, Cazzaniga M , et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36 (4) 494-500
• 23 Schepke M, Roth F, Fimmers R , et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003; 98 (5) 1167-1174
• 24 Ferral H, Gamboa P, Postoak DW , et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231 (1) 231-236
• 25 Gaba RC, Couture PM, Bui JT , et al. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2012; ; In press
• 26 Sabri SS, Swee W, Turba UC , et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011; 22 (3) 309-316 , quiz 316
• 27 Saad WE, Wagner CC, Al-Osaimi A , et al. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores. Vasc Endovascular Surg 2013; 47 (4) 281-287
• 28 Casado M, Bosch J, García-Pagán JC , et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114 (6) 1296-1303
• 29 Tripathi D, Ferguson J, Barkell H , et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006; 18 (3) 225-232
• 30 Jung HS, Kalva SP, Greenfield AJ , et al. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts. J Vasc Interv Radiol 2009; 20 (2) 180-185
• 31 Gaba RC, Omene BO, Podczerwinski ES , et al. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol 2012; 23 (2) 227-235
• 32 Jalan R, John TG, Redhead DN , et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90 (11) 1932-1937
• 33 Helton WS, Maves R, Wicks K, Johansen K. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison. Arch Surg 2001; 136 (1) 17-20
• 34 Henderson JM, Boyer TD, Kutner MH , et al; DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006; 130 (6) 1643-1651
• 35 Chalasani N, Clark WS, Martin LG , et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118 (1) 138-144
• 36 Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114 (5) 981-987
• 37 Sahagun G, Benner KG, Saxon R , et al. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Am J Gastroenterol 1997; 92 (9) 1444-1452
• 38 LaBerge JM, Somberg KA, Lake JR , et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108 (4) 1143-1151
• 39 Bañares R, Casado M, Rodríguez-Láiz JM , et al. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding. Am J Gastroenterol 1998; 93 (1) 75-79
• 40 Sommer CM, Gockner TL, Stampfl U , et al. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG). Eur J Radiol 2012; 81 (9) 2273-2280
• 41 Barrio J, Ripoll C, Bañares R , et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol 2005; 55 (1) 120-124
• 42 Bureau C, Pagan JC, Layrargues GP , et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27 (6) 742-747
• 43 Chang CJ, Hou MC, Liao WC , et al. Management of acute gastric varices bleeding. J Chin Med Assoc 2013; 76 (10) 539-546
• 44 Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol 2011; 45 (2) 133-148
• 45 Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009; 70 (5) 881-887
• 46 Lo GH, Liang HL, Chen WC , et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39 (8) 679-685
• 47 Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003; 98 (12) 2688-2693
• 48 Lunderquist A, Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med 1974; 291 (13) 646-649
• 49 Charon JP, Alaeddin FH, Pimpalwar SA , et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15 (11) 1219-1230
• 50 Tesdal IK, Filser T, Weiss C, Holm E, Dueber C, Jaschke W. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 2005; 236 (1) 360-367
• 51 Kessler J, Trerotola SO. Use of the Amplatzer Vascular Plug for embolization of a large retroperitoneal shunt during transjugular intrahepatic portosystemic shunt creation for gastric variceal bleeding. J Vasc Interv Radiol 2006; 17 (1) 135-140
• 52 Gaba RC, Bui JT, Cotler SJ , et al. Rebleeding rates following TIPS for variceal hemorrhage in the Viatorr era: TIPS alone versus TIPS with variceal embolization. Hepatol Int 2010; 4 (4) 749-756
• 53 Chen S, Li X, Wei B , et al. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology 2013; 268 (3) 900-906
• 54 Qi X, Liu L, Bai M , et al. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. J Gastroenterol Hepatol 2014; 29 (4) 688-696